Hine gained her PhD in Molecular Biology from UMIST in 1992 and her postdoctoral training at Harvard Medical School (PI: Prof Charles C. Richardson). She returned to the UK to take up a lectureship in Molecular Biology at Aston University in 1995. In 2003 she commenced her combined career in academia and innovation with a Medici Fellowship (commercialisation and entrepreneurial training), which was later followed by a secondment to the University's Business Partnership Unit as the School of Life and Health Sciences' Innovation Fellow. She was promoted to Senior Lecturer in 2006, Reader in 2013, Associate Dean in 2015 and Chair in 2018.  The mother of two children, she has worked part time (0.7/0.8 FTE) since 2003.

• Protein Engineering
• Research at the interface between molecular biology and the physical sciences
• Development of enabling technologies for biomedicines
• Protein-DNA interactions of Cys₂His₂ zinc fingers
• Protein-DNA interactions of single Cys₄ zinc fingers

Hine's research centres on combinatorial, synthetic biology and its application to protein-ligand interactions. She was named the BBSRC Commercial Innovator of the Year 2013; an award made for her successful transfer of her group’s inventions in protein engineering into UK-based Biotech company Isogenica Ltd.  Colibra^TM is now being exploited by Isogenica in the production of their highly-diverse synthetic antibody libraries.

Resulting from numerous multi-disciplinary collaborations, she also has experience of developing novel screens and in exploiting protein-DNA interactions to achieve advances in biotech process engineering.  Her interdisciplinary work has generated several photonic biosensors, a generic technology to deliver and release proteins within mammalian cells and most recently, in an international FET-OPEN project is developing synthetic replacements for monoclonal reagent antibodies.

• Prof. Dr. Andreas Plückthun, University of Zurich, Switzerland
• Prof. Dr. Birte Höcker, University of Bayreuth, Germany
• Prof. Charles C. Richardson, Harvard Medical School, USA
• Prof. David Webb, Aston University, UK
• Dr Andy Sutherland, Aston University, UK
• Isogenica Ltd., Cambridge, UK

• 2013 BBSRC Commercial Innovator of the Year
• 2013 Aston Excellence Award for Outstanding Contribution to Innovation and/or Technological Improvement

• Fellow of the Royal Society of Biology
• Member of the Biochemical Society
• Senior Fellow of the Higher Education Academy

• 2018-date Professor of Protein Engineering, Aston University
• 2015-date Associate Dean, Enterprise, Aston University
• 2013-2018 Reader in Molecular Biology, Aston University
• 2009-2012 Course Director, MSc Biotechnology, Aston University
• 2006-2013 Senior Lecturer in Molecular Biology, Aston University
• 2005-2006 LHS Innovation Fellow, Business Partnership Unit (partial secondment), Aston University
• 2004-2005 CEO, ProtaMAX Ltd
• 2003-2004 Medici Fellow (Commercialisation and Entrepreneurial Training)
• 1995-2006 Lecturer in Molecular Biology, Aston University
• 1993-94 Research Fellow, Harvard Medical School (PI: Prof. C.C. Richardson)

• 1989-92 PhD, UMIST (Supervisor: Prof. T.A. Brown)
• 1986-89 BSc Hons Biochemistry and Applied Molecular Biology (Class I) UMIST (now integrated into the University of Manchester)

Email: [email protected] 
Telephone: +44 (0) 121 204 3961